Public signalCompany raiseAuto-indexed · Unverified
Opus Genetics, Inc. raised $25.8M
Opus Genetics, Inc.· Farmington Hills, US· Biotechnology· Filed Nov 7, 2024
Opus Genetics, Inc. reported raising capital. Based in Farmington Hills, MICHIGAN, US. First sale reported 2024-10-22. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$25.8M
Confidence90%
Raised
$25.8M
Investors
11
Jurisdiction
DELAWARE
On the record
- Location
- Farmington Hills, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $25.8M
- Target amount
- $25.8M
- Filing date
- Nov 7, 2024
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Industry group
- Biotechnology
- Number of investors
- 11
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $25.8M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Amy Rabourn
Executive Officer
Farmington Hills, US
Ash Jayagopal
Executive Officer
Farmington Hills, US
Bernhard Hoffmann
Executive Officer
Farmington Hills, US
Cam Gallagher
Director
Farmington Hills, US
Dr. Adrienne Graves
Director
Farmington Hills, US
Dr. Benjamin Yerxa
Director
Farmington Hills, US
Dr. George Magrath
Executive Officer
Farmington Hills, US
Dr. Jean Bennett
Director
Farmington Hills, US
James Manuso
Director
Farmington Hills, US
Joseph Schachle
Executive Officer
Farmington Hills, US
Nirav Jhaveri
Executive Officer
Farmington Hills, US
Richard Rodgers
Director
Farmington Hills, US
Sean Ainsworth
Director
Farmington Hills, US
Susan Benton
Director
Farmington Hills, US
Sources & provenance
“Operating company sold 25,778,641 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Nov 7, 2024. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Opus Genetics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record